syndrome sjs type severe skin together toxic epidermal necrolysis ten epidermal necrolysis sjsten forms spectrum disease sjs less erythema multiforme em generally considered separate early symptoms sjs include fever flulike days later skin begins blister peel forming painful raw mucous membranes mouth also typically complications include dehydration sepsis pneumonia multiple organ common cause certain medications lamotrigine carbamazepine allopurinol sulfonamide antibiotics causes include infections mycoplasma pneumoniae cytomegalovirus cause may remain risk factors include hivaids systemic lupus diagnosis syndrome based involvement less known ten skin involved considered intermediate form sjsten reactions believed follow type iv hypersensitivity also included drug reaction eosinophilia systemic symptoms dress syndrome acute generalized exanthematous pustulosis agep toxic epidermal necrolysis group conditions known severe cutaneous adverse reactions treatment typically takes place hospital burn unit intensive care efforts may include stopping cause pain medication antihistamines antibiotics intravenous immunoglobulins together ten sjs affects people per million per typical onset age skin usually regrows two three weeks however complete recovery take overall risk death sjs sjs usually begins fever sore throat fatigue commonly misdiagnosed therefore treated antibiotics sjs sjsten ten often heralded fever sore throat cough burning eyes patients disorders frequently experience burning pain skin start ulcers lesions begin appear mucous membranes almost always mouth lips also genital anal regions mouth usually extremely painful reduce patients ability eat drink conjunctivitis occurs children develop rash round lesions inch across arises face trunk arms legs soles feet usually mucosal desquamation person syndrome inflammation peeling sores presenting tongue mucous membranes sjs conjunctivitis sjs sjs thought arise disorder immune immune reaction triggered drugs genetic factors associated predisposition cause sjs unknown onequarter onehalf sjs sjsten ten considered single disease common causes individuals expressing certainspecify human leukocyte antigen ie hla serotypes ie genetic alleles geneticalbased cell receptors variations efficiency absorb distribute tissues metabolize excrete combination termed adme drug predisposed develop sjscitation needed although sjs caused viral infections malignancies main cause leading cause appears use antibiotics particularly sulfa different drugs may associated reliable test exists establish link particular drug sjs individual determining drug cause based time interval first use drug beginning skin reaction drugs discontinued month prior onset mucocutaneous physical findings highly unlikely cause sjs sjs ten often begin days culprit drug published algorithm alden assess drug causality gives structured assistance identifying responsible sjs may caused medications vancomycin allopurinol valproate levofloxacin diclofenac etravirine isotretinoin valdecoxib sitagliptin oseltamivir penicillins barbiturates sulfonamides phenytoin azithromycin oxcarbazepine zonisamide lamotrigine pyrimethamine ethosuximide carbamazepine bupropion medications traditionally known lead sjs erythema multiforme toxic epidermal necrolysis include sulfonamide penicillin antibiotics cefixime antibiotic barbiturates sedatives lamotrigine phenytoin eg dilantin anticonvulsants trimethoprim combining lamotrigine sodium valproate increases risk nonsteroidal antiinflammatory drugs nsaids rare cause sjs adults risk higher older patients women initiating typically symptoms druginduced sjs arise within week starting medication similar nsaids paracetamol acetaminophen also caused rare sjs people systemic lupus erythematosus hiv infections susceptible druginduced second common cause sjs ten infection particularly children includes upper respiratory infections otitis media pharyngitis virus mycoplasma pneumoniae cytomegalovirus infections routine use medicines antibiotics antipyretics analgesics manage infections make difficult identify cases caused infection medicines viral diseases reported cause sjs include herpes simplex virus possibly debated aids coxsackievirus influenza hepatitis pediatric cases virus enteroviruses associated recent upper respiratory tract infections reported half patients bacterial infections linked sjs include group betahemolytic streptococci diphtheria brucellosis lymphogranuloma venereum mycobacteria mycoplasma pneumoniae rickettsial infections tularemia fungal infections coccidioidomycosis dermatophytosis histoplasmosis also considered possible malaria trichomoniasis protozoal infections also reported sjs type iv hypersensitivity reaction drug metabolite stimulates cytotoxic cells ie cells helper cells ie cells initiate autoimmune reactions attack self tissues particular type iv subtype ivc delayed hypersensitivity reaction dependent part tissueinjuring actions natural killer contrasts types scars disorders ie dress syndrome type iv subtype ivb hypersensitivity drug reaction dependent part tissueinjuring actions acute generalized exanthematous pustulosis type iv subtype ivd hypersensitivity reaction dependent part tissueinjuring actions like scarsinducing drugs sjsinducing drugs metabolites stimulate cells cells initiate autoimmune responses studies indicate mechanism drug metabolites accomplishes involves subverting antigen presentation pathways innate immune system drug metabolite covalently binds host protein form nonself drugrelated epitope antigen presenting cell apc takes alter proteins digests small peptides places peptides groove human leukocyte antigen ie hla component major histocompatibility complex ie mhc presents mhcassociated peptides tcell receptors cells cells peptides expressing drugrelated nonself epitope one various hla protein forms hlaa hlab hlac hladm hlado hladp hladq hladr bind tcell receptor thereby stimulate receptorbearing parent cell initiate attacks self tissues alternatively drug metabolite may stimulate cells inserting groove hla protein serve nonself epitope bind outside groove alter hla protein forms nonself epitope cases however nonself epitope must bind specific hla serotype ie variation order stimulate cells since human population expresses different hla serotypes individual expresses fraction since sjsinducing drug metabolite interacts one hla serotypes drugs ability induce scars limited individuals express hla serotypes targeted drug accordingly rare individuals predisposed develop scars response particular drug bases expression hla studies identified several hla serotypes associated development sjs sjsten ten response certain general associations restricted cited east asian populations studied han chinese thai carbamazepine phenytoininduced sjs strongly associated hlab serotype broader serotype study europe suggested gene marker relevant east clinical relevance agreed upon prior starting medication allopurinol patient chinese descent testing based asian findings similar studies europe showed allopurinolinduced sjsten patients carried phenotype frequency allele europeans typically one study concluded even hlab alleles behave strong risk factors allopurinol neither sufficient necessary explain hla associations development sjs sjsten ten intake specific drugs determined certain populations given hla associations scars addition acting hla proteins bind tcell receptor drug metabolite may bypass hla proteins bind directly tcell receptor thereby stimulate cells initiate autoimmune responses either case binding appears develop certain cell receptors since genes receptors highly edited ie altered encode proteins different amino acid sequences since human population may express trillion different ie different amino acid sequences tcell receptors individual express fraction drugs metabolites ability induce dress syndrome interacting cell receptor limited individuals whose cells express cell receptors interact drug thus rare individuals predisposed develop sjs response particular drug bases expression specific tcell receptor evidence supporting tcell receptor selectivity limited one study identified preferential presence tcrvb complementaritydetermining region tcell receptors found cells blisters patients allopurinolinduced dress syndrome finding compatible notion specific types cell receptors involved development specific druginduced variations adme ie individuals efficiency absorbing tissuedistributing metabolizing excreting drug found occur various severe cutaneous adverse reactions scars well types adverse drug variations influence levels duration drug metabolite tissues thereby impact drugs metabolites ability evoke example important drugmetabolizing cytochrome metabolizes thereby inactivates phenytoin taiwanese japanese malaysian individuals expressing variant reduced metabolic activity compared wild type ie cytochrome increased blood levels phenytoin high incidence sjs well sjsten ten taking addition abnormalities drugmetabolizing enzymes dysfunctions kidney liver gi tract increase scarsinducing drug metabolite levels suggested promote scars adme abnormalities also suggested may interact particular hla proteins cell receptors promote scars diagnosis based involvement less known ten skin involved intermediate form positive nikolskys sign helpful diagnosis sjs skin biopsy helpful required establish diagnosis sjs sjs like ten erythema multiforme characterized confluent epidermal necrosis minimal associated inflammation acuity apparent normal basket weavelike pattern stratum corneum syndrome sjs milder form toxic epidermal necrolysis conditions first recognised classification first published adopted consensus definition identifies syndrome toxic epidermal necrolysis sjsten overlap three part spectrum severe cutaneous reactions scar affect skin mucous distinction sjs sjsten overlap ten based type lesions amount body surface area blisters agreed reliable method classify em sjs ten based lesion morphology extent epidermal blisters erosions cover body sjs sjsten overlap skin pattern commonly associated sjs widespread often joined touching confluent papuric spots macules flat small blisters large blisters may also occur primarily sjs ten sjsten overlap mistaken erythema erythema multiforme also within scar spectrum differs clinical pattern screening individuals certain predisposing gene variants initiating treatment particular sjs tensjs teninducing drugs recommended study recommendations typically limited specific populations show significant chance indicated gene variant since screening populations extremely low incidences expressing variant considered individuals expressing hla allele associated sensitivity indicated drug treated drug recommendations include treatment carbamazepine taiwan usa food drug administrations recommend screening certain asian groups implemented taiwan hong kong singapore many medical centers thailand mainland china treatment allopurinol american college rheumatology guidelines managing gout recommend screening provided many medical centers taiwan hong kong thailand mainland china treatment abacavir usa food drug administration recommends screening caucasian populations screening widely implementedcitation needed also suggestedby individuals found express hla serotype avoid treatment abacovir current trials underway taiwan define costeffectiveness avoiding phenytoin sjs sjsten ten individuals expressing allele sjs constitutes dermatological emergency patients documented mycoplasma infections treated oral macrolide oral initially treatment similar patients thermal burns continued care supportive eg intravenous fluids nasogastric parenteral feeding symptomatic eg analgesic mouth rinse mouth ulcer dermatologists surgeons tend disagree whether skin beyond kind supportive care treatment sjs accepted treatment corticosteroids controversial early retrospective studies suggested corticosteroids increased hospital stays complication rates randomized trials corticosteroids conducted sjs managed successfully without agents used including cyclophosphamide ciclosporin none exhibited much therapeutic success intravenous immunoglobulin treatment shown promise reducing length reaction improving symptoms common supportive measures include use topical pain anesthetics antiseptics maintaining warm environment intravenous analgesics ophthalmologist consulted immediately sjs frequently causes formation scar tissue inside eyelids leading corneal vascularization impaired vision host ocular problems chronic ocular surface disease caused sjs may find improvement prose treatment prosthetic replacement ocular surface ecosystem sjs less body surface area involved mortality rate around mortality toxic epidermal necrolysis ten risk death estimated using scorten scale takes number prognostic indicators helpful calculate scorten within first days outcomes include organ damagefailure ocular morbidity restrictive lung disease may develop patients sjs ten initial acute pulmonary patients sjs ten caused drug better prognosis earlier causative drug sjs rare condition reported incidence around cases per million people per year united states new diagnoses made year condition common adults children sjs named albert mason stevens frank chambliss johnson american pediatricians jointly published description disorder american journal diseases children nih food drug administration fda organized workshop entitled research directions geneticallymediated syndrometoxic epidermal